Renergen, an emerging domestic natural gas and helium producer, has developed a ground-breaking device that keeps Covid-19 vaccines ultra-cold during transportation for up to 30 days, allowing for the vaccines to travel for longer and reach remote areas.

The Renergen Cryo-Vacc will simplify the logistics of moving vaccines at extremely cold temperatures of between -70°C and -150°C for more than four weeks and without the need for any power supply...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now